CTC utökar sitt erbjudande inom fas II-studier

Besök hos Astra Zenecas produktionsanläggning

Under sommaren stänger Astra Zeneca av produktionen under två veckor för underhållsarbete. Jerry Johansson, Head of Engineering Maintenance & Asset Management, har gett oss en inblick i stoppet.

Svenskt företag bygger första fabriken för covidvaccin i Afrika

Stockholmsföretaget Keyplants har ingått ett avtal om att bygga Afrikas första produktionsanläggning för vaccin mot covid-19.

Sweden and Denmark – this is how they choose their strategies

Scandinavia’s two major powers in pharmaceutical research have developed strategies for growth in life science, and both countries aim to become world leaders.

Cytiva går för högtryck – nyanställer 300

Läkemedelsföretaget Cytiva fortsätter att expandera i covidpandemins spår. Bara i år räknar företaget med att nyanställa över 300 personer i Uppsala och Umeå.

Norway finds its path in life science

The life science sector in Norway is on the rise.

Marie Gårdmark: Big data evidence generation drives change in the EU regulatory system

Rapid developments in technology have led to the possibility for the generation and analysis of vast volumes of data. Will the availability of big data lead to fundamental changes to the regulatory system? In a column Marie Gårdmark, CEO and Senior Consultant at RegSmart Life Science, develops her views on this subject.

Column: Why there cannot be a complete cure for cancer – but there is certainly another way!

"Is there a new way we need to be thinking about how to prevent cancer?" Lucy Robertshaw reflects upon which is the smartest way to beat cancer.

Column: "Are we already living in the new normal?"

2020 felt like the year that we were building the house around us whilst moving into it at the same time.

Årets opinionsartiklar

Missa inte de opinionsartiklar som har blivit mest lästa i Life Science Sweden.

New diagnostic test soon ready for the market

Stort intresse för New Horizons

Just nu pågår livesändningen av Life Science Swedens event New Horizons in Biologics & Bioprocessing – och intresset är rekordstort.

Lucy Robertshaw: There is a bio revolution happening right now

Lucy Robertshaw is both proud and excited to be taking the baton of moderating this year’s Pharma Outsourcing event.

Combining two drug delivery strategies to improve bioavailability

Danish researchers hope to increase the bioavailability of low solubility drugs.

Delivering drugs with small devices

There are many challenges to overcome when delivering a drug orally. Getting the drug to survive the low pH of the ventricle and being released at the correct site in the gastrontestinal tract are two of them.

Marie Gårdmark: Do EMA and FDA talk to each other?

Of course they do! The collaboration started already in 2003, writes Marie Gårdmark in a column.

Maja Johansson blir chef för nya vaccinanläggningen i Umeå

Sedan en månad tillbaka är Maja Johansson ny site manager för Diamyd Medicals nya tillverkningsenhet i Umeå.

Giulia Gaudenzi: ”Key lessons from global health research”

The world will still face major challenges in the post Covid-19 pandemic, writes Giulia Gaudenzi at the KTH Division of Nanobiotechnology at Scilifelab, in a column.

Helena Strigård: The rise of the community

Sweden Bio´s CEO is looking back at the last decade of development in the industry. Something has shifted in the interdependence between small and larger companies.

Pilots want to live too

Drug development creates new challenges for regulators

Krönika: Can regulators keep up with innovation?

New technology has increased the understanding of disease mechanisms and enabled approval of products targeting small but specific patient populations; sometimes referred to as precision medicine. Gene- and cell therapies have reached the market, exemplified by CAR-T cells, and the research pipeline is promising. In addition, the medical device field is constantly growing creating new solutions to address patient needs.

Brexit looking back and looking forward

More than 3 years have passed after the vote and there is still uncertainty around the outcome although the UK December 12 election set a clearer course towards an exit early 2020.

Engage with your CMO early

Gordon Hutton is Materials Science Lead at Thermo Fisher Scientific’s, formerly GSK, small molecule API site in Cork, Ireland.